- The Marker: Mego Afek and COVID-19 related innovation and growth initiatives
Mego Afek is honored to have been featured in the exclusive magazine by The Marker, one of Israel’s leading financial publications, covering COVID-19 related innovation and growth initiatives.
Barak Hoffer, Mego’s CEO, talked about two important innovative projects we are involved in, to assist treatment in Coronavirus patients.
Link to the article on The Marker Magazine: https://www.haaretz.co.il/st/inter/Global/magazine/Haaretz/2020/Israel.mag_6.20/index.html#p=24
- The Lympha TrackTM mobile application is now available in multiple languages
Lympha TrackTM has been recently adopted to multiple languages, so that patients all over the world can easily track lymphedema symptoms and retain their progress with the user-friendly application.
Lympha TrackTM is a free application, now available in English, Spanish,German, French and Russian , in both iOS version (available in the App Store) and in an Android version, (available in Google Play). Learn more about the benefits and features here.
- Preliminary data shows Lympha Press PCD-51 effective at healing chronic venous stasis ulcers
A new study with Lympha Press® PCD-51™ was presented at the Symposium on Advanced Wound Care, Spring, May 2019, San Antonio TX USA.
The study showed complete healing of chronic venous stasis ulcers in four out of five patients, and partial healing in the fifth patient, at the end of the eight-week treatment phase. Treatment consisted of twice-daily treatments with Lympha Press® PCD-51™ with full leg sleeves, and multilayer compression bandaging up to the knee.
All patients saw a reduction in edema, pain, exudate and odor.
Click here for details.